Articles dans des revues avec comité de lecture (76)
  1. 35. Maetens, M. M., Doumont, G., De Clercq, S., Francoz, S., Froment, P., Bellefroid, E., Klingmuller, U., Lozano, G., & Marine, J.-C. (2007). Distinct roles of Mdm2 and Mdm4 in red cell production. Blood, 109(6), 2630-2633.
  2. 36. Beekman, C., Nichane, M., De Clercq, S., Maetens, M. M., Floss, T., Wurst, W., Bellefroid, E., & Marine, J.-C. (2006). Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development. Molecular and cellular biology, 26(24), 9291-9301. doi:10.1128/MCB.01183-06
  3. 37. Cartry, J., Nichane, M., Ribes, V., Colas, A., Riou, J.-F., Pieler, T., Dollé, P., Bellefroid, E., & Umbhauer, M. (2006). Retinoic acid signalling is required for specification of pronephric cell fate. Developmental biology, 299(1), 35-51. doi:10.1016/j.ydbio.2006.06.047
  4. 38. Nichane, M., Van Campenhout, C., Pendeville, H., Voz, M. L., & Bellefroid, E. (2006). The Na+/PO4 cotransporter SLC20A1 gene labels distinct restricted subdomains of the developing pronephros in Xenopus and zebrafish embryos. Gene expression patterns, 6(7), 667-672. doi:10.1016/j.modgep.2006.01.005
  5. 39. Taelman, V., Van Campenhout, C., Solter, M., Pieler, T., & Bellefroid, E. (2006). The Notch-effector HRT1 gene plays a role in glomerular development and patterning of the Xenopus pronephros anlagen. Development, 133(15), 2961-2971. doi:10.1242/dev.02458
  6. 40. van Grunsven, L. A., Taelman, V., Michiels, C., Opdecamp, K., Huylebroeck, D., & Bellefroid, E. (2006). deltaEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis. Developmental dynamics, 235(6), 1491-1500. doi:10.1002/dvdy.20727
  7. 41. Van Campenhout, C., Nichane, M., Antoniou, A., Pendeville, H., Bronchain, O., Marine, J.-C., Mazabraud, A., Voz, M. L., & Bellefroid, E. (2006). Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation. Developmental biology, 294(1), 203-219. doi:10.1016/j.ydbio.2006.02.040
  8. 42. Rothé, F., Gueydan, C., Bellefroid, E., Huez, G., & Kruys, V. (2006). Identification of FUSE-binding proteins as interacting partners of TIA proteins. Biochemical and biophysical research communications, 343(1), 57-68. doi:10.1016/j.bbrc.2006.02.112
  9. 43. Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M. M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006). Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 103(9), 3232-3237. doi:10.1073/pnas.0508476103
  10. 44. Solter, M., Locker, M., Boy, S., Taelman, V., Bellefroid, E., Perron, M., & Pieler, T. (2006). Characterization and function of the bHLH-O protein XHes2: Insight into the mechanisms controlling retinal cell fate decision. Development, 133, 4097-4108. doi:10.1242/dev.02567
  11. 45. Doumont, G., Martoriati, A., Beekman, C., Bogaerts, S., Mee, P. J., Bureau, F., Colombo, E., Alcalay, M., Bellefroid, E., Marchesi, F., Scanziani, E., Pelicci, P. G., & Marine, J.-C. (2005). G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv. EMBO journal, 24(17), 3093-3103. doi:10.1038/sj.emboj.7600769
  12. 46. Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J.-C. (2005). dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene, 24(8), 1461-1466. doi:10.1038/sj.onc.1208256
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>